Extracorporeal Membrane Oxygenation to Support COVID-19 Patients: A Propensity-Matched Cohort Study

CONCLUSION: ECMO therapy may be associated with an up to a three-fold increase in ICU mortality and 3-month mortality compared to MVA despite the facilitation of lung-protective ventilation settings in mechanically ventilated COVID-19 patients. We cannot confirm the positive results of the first propensity-matched cohort study on this topic. This trial is registered with NCT05158816.PMID:37342313 | PMC:PMC10279486 | DOI:10.1155/2023/5101456
Source: Critical Care Research and Practice - Category: Intensive Care Authors: Source Type: research